| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 791.76M | 683.62M | 556.20M | 516.28M | 499.62M |
| Gross Profit | 228.19M | 189.94M | 176.50M | 196.84M | 201.61M |
| EBITDA | 87.20M | 94.00M | 221.53M | 248.63M | 260.43M |
| Net Income | -59.62M | 90.89M | 112.40M | 142.61M | 153.94M |
Balance Sheet | |||||
| Total Assets | 2.92B | 2.53B | 2.47B | 2.34B | 2.28B |
| Cash, Cash Equivalents and Short-Term Investments | 559.83M | 364.22M | 423.52M | 248.98M | 552.44M |
| Total Debt | 519.82M | 284.48M | 322.31M | 342.51M | 416.80M |
| Total Liabilities | 1.36B | 873.22M | 814.53M | 798.59M | 823.45M |
| Stockholders Equity | 1.56B | 1.66B | 1.65B | 1.54B | 1.46B |
Cash Flow | |||||
| Free Cash Flow | 43.08M | -7.54M | 51.27M | 110.65M | 42.98M |
| Operating Cash Flow | 230.19M | 285.34M | 268.24M | 308.42M | 195.85M |
| Investing Cash Flow | -188.85M | -296.98M | -63.95M | -352.62M | -260.09M |
| Financing Cash Flow | 133.24M | -128.65M | -30.41M | -190.49M | 258.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.22B | 1.78 | 21.69% | 10.76% | 6.22% | 7.79% | |
72 Outperform | HK$2.45B | 7.32 | 37.38% | 5.86% | 72.87% | 54.16% | |
70 Outperform | HK$1.70B | 2.89 | 13.50% | 9.42% | 19.80% | -10.87% | |
69 Neutral | HK$546.00M | 1.54 | 7.04% | ― | 12.52% | -33.22% | |
63 Neutral | HK$619.30M | 1.58 | 8.40% | 11.09% | 1.47% | 1.93% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | HK$192.10M | -2.78 | -3.49% | 11.00% | 15.94% | -168.02% |